Search Results
Aug 28, 2026, 19:00 ET 디지털 미러 선도기업 와이포어, 북미에서 지능형 미러 전체 라인업 공개
테크놀로지(YFORE Technology)가 오늘 조지아주 애틀랜타 인근에 새로 건설한 생산시설을 공식 가동했다. 와이포어는 이를 기념해 인테리어 다기능 미러(Multifunctional Mirror)의 글로벌 첫 공개를 필두로 실내 디지털 미러(CMS-I), 실외 사이드 미러(CMS-III), 자동 조광 미러(Auto-Dimming Mirror)를 아우르는 디지털 미러 전체 라인업을 북미 시장에 선보였다.
More news about: YFORE
Aug 28, 2026, 16:20 ET Aardvark Therapeutics, Inc. (AARD) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
safe than Defendants had led investors to believe; (ii) accordingly, ARD-101's clinical, regulatory, and commercial prospects were overstated; and (iii) as a result, Defendants' public statements were materially false and misleading at all relevant times.Contact Us To Participate or Learn More:
More news about: Law Offices of Howard G. Smith
Aug 28, 2026, 16:15 ET Nektar Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
including negative safety and efficacy findings in future clinical studies (notwithstanding positive findings in earlier preclinical and clinical studies); (iii) rezpegaldesleukin, NKTR-0165, NKTR-0166 and NKTR-422 are in various stages of preclinical and clinical development, the risk of failure is high and
More news about: Nektar Therapeutics
Aug 28, 2026, 15:39 ET デジタルミラーのパイオニアであるYFORE、北米でスマートミラーのフルラインナップを発表
ジョージア州スワニー、2026年8月29日 /PRNewswire/ -- 世界をリードするTier-1自動車用電子部品サプライヤーであるYFORE Technologyは、ジョージア州アトランタ近郊に新設した米国製造施設を正式に稼働させました。今回の節目を記念して、YFOREは北米全域でデジタルミラーのフルラインナップを発表しました。これには、インテリアデジタルミラー（CMS-I）、エクステリアサイドミラー（CMS-III）、オートディミングミラーが含まれており、中でも多機能ミラーの世界初公開が注目を集めました。
More news about: YFORE
Aug 28, 2026, 14:42 ET YFORE, pionnier des rétroviseurs numériques, dévoile sa gamme complète de rétroviseurs intelligents en Amérique du Nord
complète de rétroviseurs numériques en Amérique du Nord, comprenant des rétroviseurs intérieurs numériques (CMS-I), des rétroviseurs extérieurs latéraux (CMS-III) et des rétroviseurs à atténuation automatique, avec en tête d'affiche la première mondiale de son rétroviseur multifonctionnel.
More news about: YFORE
Aug 28, 2026, 14:40 ET GoDaddy Inc. (GDDY) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
Company had implemented a promotional discount for dotcom domains that were likely to and did result in shorter term contracts with smaller valuations; (iii) the Company's institution of a promotional discount on one- year dotcom contracts with shorter terms was already having a material, negative impact
More news about: The Law Offices of Frank R. Cruz, Los Angeles
Aug 28, 2026, 13:59 ET Civitas Closes $104 Million Senior Loan for 164-Unit Class A Multifamily Community in Colorado's Vail Valley
project.The Summit is Civitas' sixth rural EB-5 project in Colorado, following Civitas Aspen Fund, Civitas Aspen Fund II, Civitas Aspen Fund III, Civitas Silverthorne, and Civitas Steamboat. Those five rural projects created EB-5 investment opportunities for over 200 families.The Summit
More news about: CIVITAS CAPITAL GROUP
Aug 28, 2026, 13:52 ET UMD Smith Appoints Former BECU CRO John Stewart to Lead the Smith Enterprise Risk Consortium
expansion."Stewart's background spans enterprise risk management, credit and operational risk, market risk and interest-rate risk modeling, economic capital, and Basel III frameworks, along with corporate strategy and leadership. His experience as both a consultant and a corporate executive gives him a broad perspective
More news about: University of Maryland's Robert H. Smith School of Business
Aug 28, 2026, 13:06 ET Liberty Restoration Group Expands Midwestern Footprint with Acquisitions of ServiceMaster of Columbia & ServiceMaster Restoration Services by KRS
recapitalizations, acquisitions, growth capital, generational transitions, and buyouts. SharpVue is currently investing from SharpVue Capital Credit Fund III, L.P., an SBIC fund. For more information, please visit www.sharpvuecapital.com.About
More news about: ServiceMaster Brands
Aug 28, 2026, 12:23 ET LifeTech Scientific Corporation Announces 2026 Interim Results
non-recurring items include (i) the other losses arising from financial assets at fair value through profit or loss; (ii) the share-based payment expenses; and (iii) the transaction expenses in connection with a proposed transaction involving the conditional acquisition of equity interest in Starway Medical Technology,
More news about: LifeTech Scientific Corporation
Aug 28, 2026, 11:10 ET WIX INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Wix.com Ltd. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit Before September 22, 2026 Deadline
relative to those offered by other companies; (ii) Wix had understated the costs associated with developing and promoting its AI product offerings; and (iii) accordingly, defendants overstated the commercial and financial benefits of Wix' AI product offerings.On May 21, 2025, Wix issued a press release
More news about: Robbins Geller Rudman & Dowd LLP
Aug 28, 2026, 11:05 ET 1 MONTH CAPR INVESTOR DEADLINE: Capricor Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Capricor Class Action Lawsuit Before September 28, 2026 Deadline
data for Deramiocel; (ii) the FDA had not agreed to those changes before Capricor resubmitted the Deramiocel Biologics License Application ("BLA"); (iii) as a result, there was a significant risk that the FDA could conclude the clinical results did not provide substantial evidence of effectiveness of
More news about: Robbins Geller Rudman & Dowd LLP
Aug 28, 2026, 10:42 ET YFORE, pionera en espejos digitales, presenta su gama completa de espejos inteligentes en Norteamérica
Norteamérica su gama completa de retrovisores digitales, que abarca retrovisores interiores digitales (CMS-I), retrovisores laterales exteriores (CMS-III) y retrovisores con atenuación automática, encabezada por el estreno mundial de su retrovisor multifuncional.
More news about: YFORE
Aug 28, 2026, 10:34 ET SF Intra-city's Strategic Leadership Drives Performance to New Heights in 1H 2026
its full–scenario, multi–category service capabilities enabling it to maintain good cooperative relationships with a multi–layered customer base; and (iii) further enhancement of economies of scale, optimisation of resource input strategies, refined rider network operations and the application of AI technologies
More news about: SF Intra-city
Aug 28, 2026, 10:10 ET BLACK PEARL EXTENDS TENDER OFFER FOR ALL OUTSTANDING SHARES OF SELECTIS HEALTH, INC.
satisfaction of the conditions to closing the transaction in the anticipated timeframe or at all; (ii) the failure to obtain necessary regulatory approvals; (iii) the ability to realize the anticipated benefits of the transaction; (iv) the ability to successfully integrate the businesses; (v) disruption from the
More news about: Black Pearl Equities
Aug 28, 2026, 09:59 ET YFORE, Pionier im Bereich digitaler Spiegel, stellt in Nordamerika sein komplettes Sortiment an intelligenten Spiegeln vor
Meilensteins stellte YFORE sein komplettes Sortiment an digitalen Spiegeln in ganz Nordamerika vor, das digitale Innenspiegel (CMS-I), digitale Außenspiegel (CMS-III) und automatisch abblendbare Spiegel umfasst, angeführt von der weltweiten Premiere seines Multifunktionsspiegels.
More news about: YFORE
Aug 28, 2026, 07:30 ET Kazia Therapeutics Limited Announces Pricing of Up to $120 Million Public Offering
Company's Stage IV triple-negative breast cancer (TNBC) data readout, expected in the second half of 2027, or the five-year anniversary of issuance, and (iii) accompanying Series B Warrants to purchase up to 2,064,000 ADSs (or pre-funded warrants in lieu thereof), which are exercisable immediately at a purchase
More news about: Kazia Therapeutics Limited
Aug 28, 2026, 07:00 ET InxMed Announces Publication in The Lancet Oncology Featuring Encouraging Antitumor Activity of Ifebemtinib in Combination with Garsorasib in Previously Treated Metastatic Colorectal Cancer (CRC) Harboring KRAS G12C Mutation
pivotal trial of this combination regimen to further establish its clinical benefit. The company has submitted an IND application in China, for a phase III trial evaluating the efficacy and safety of ifebemtinib plus garsorasib versus investigators' choice of standard therapy for treatment of previously
More news about: InxMed Co., Ltd
Aug 28, 2026, 06:47 ET Digital Mirror Pioneer YFORE Unveils Full Intelligent Mirror Lineup in North America
the milestone, YFORE debuted its full digital mirror lineup across North America, spanning Interior Digital Mirrors (CMS-I), Exterior Side Mirrors (CMS-III), and Auto-Dimming Mirrors, led by the global debut of its Multifunctional Mirror.
More news about: YFORE
Aug 28, 2026, 06:23 ET Digital Mirror Pioneer YFORE Unveils Full Intelligent Mirror Lineup in North America
the milestone, YFORE debuted its full digital mirror lineup across North America, spanning Interior Digital Mirrors (CMS-I), Exterior Side Mirrors (CMS-III), and Auto-Dimming Mirrors, led by the global debut of its Multifunctional Mirror.
More news about: YFORE
Aug 28, 2026, 06:10 ET SEPTEMBER 21, 2026 INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Files Class Action Lawsuit Against Cogent Communications Holdings, Inc. and Announces that Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - CCOI
wavelength in a timely manner; (iii) that, as a result of (i)-(ii) above, defendants had materially misrepresented customer demand for Cogent's optical wavelength services and the nature of Cogent's purported "backlog" of wavelength orders; (iv) that, as a result of (i)-(iii) above, Cogent was not on track
More news about: Robbins Geller Rudman & Dowd LLP
Aug 28, 2026, 04:34 ET MINISO Group Announces 2026 June Quarter and Interim Unaudited Financial Results
(the "Equity Linked Securities"), and (iii) increased interest expenses mainly attributable to a borrowing in connection with the acquisition of the equity interest in Yonghui Superstores Co., Ltd * (永輝超市股份有限公司) ("Yonghui"). Both (ii) and (iii) are excluded in non-IFRS financial measures(2)
More news about: MINISO Group Holding Limited
Aug 27, 2026, 22:44 ET Akeso 2026 Interim Results: Strong Commercialization Momentum; IO2.0+ Global Strategy Redefining Clinical Standards; Bispecific Advancement in ADC, I&I and Alzheimer's
chemotherapy in a randomized, double-blind Phase III trial. Ivonescimab combination therapy marks a significant advance in first-line sq-NSCLC treatment.EGFR-TKI-resistant NSCLC: In July 2026, an updated analysis of the global multicenter Phase III HARMONi study demonstrated continued OS improvement
More news about: Akeso, Inc.
Aug 27, 2026, 18:58 ET Samsung Biologics Announces KRW 3 Trillion Rights Offering to Fund Its Next-Phase Expansion
Rockville, Maryland, U.S., Samsung Biologics holds total global manufacturing capacity of 845,000 liters. The company has also secured land for Bio Campus III, laying the groundwork for future capacity expansion to support next-generation therapies and emerging modalities.Samsung Biologics
More news about: Samsung Biologics
Aug 27, 2026, 18:20 ET Ecopetrol Announces the Second Convening of Bondholders' Meetings for Domestic Public Debt Bonds
Bondholders' Representatives for the appointment of the Chairperson and Secretary of the meeting, in accordance with Section 4.3.3 of Chapter I, Title I, Part III of Legal Circular 006 of 2025 issued by the Superintendencia Financiera de Colombia (Colombian Financial Superintendence).Appointment of the
More news about: Ecopetrol S.A.